NeurAxis logo

NeurAxis

NRXS | AMEX
Chart Builder DCF Calculator
$4.80
-$0.62 (-11.44%)
At close: Nov 16, 2026, 4:00 PM ET
$4.73
-$0.07 (-1.46%)
After-hours: Nov 16, 2026, 5:46 PM ET
-11.44%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
54.2
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #201/1021 (Top 20%)

Key Statistics

Market Data

Market Cap $68.13M
1D Range
4.71 5.30
52W Range
2.31 8.81

Valuation (TTM)

PE -4.57
PB 18.81
EV/EBITDA -5.36

Valuation (NTM)

Forward PE N/A
Forward PEG 0.27
Price Target $8.00
Loading financial charts...

Profile

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to al...

Sector Healthcare
Industry Biotechnology
Employees 24
IPO Date Aug 9, 2023
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
-$0.52
Miss -147.62%
REV
$2.03M
Miss -3.43%
Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$8.00
Upside
+66.67%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.